LINKÖPING, Sweden, March 8, 2024 /PRNewswire/ — International medical imaging IT and cybersecurity company Sectra’s (STO: SECT B) enterprise imaging module for radiology once again received a top ranking in customer satisfaction surveys in the US, Canada and Europe. Satisfied and loyal customers are the basis for growth in all operating areas and contributed to order bookings surpassing SEK 5 billion during the nine-month period.
Quarter (November 2023–January 2024) in figures
Nine-month period (May 2023–January 2024) in figures
Comments from Torbjörn Kronander, President and CEO of Sectra AB:
“A sustainable future is about making our customers successful. I can’t repeat this enough. To succeed we must have satisfied customers, which in turn requires that we have satisfied employees and a corporate culture that encourages engagement and motivation. At Sectra, we are proud that our customers time and time again say how satisfied they are with our employees and our efforts to make a positive difference in society.
All of our operating areas are growing. Secure Communications is continuing to make a more significant contribution to the Group’s profit than in the past and, for the first time, exceeded SEK 300 million in sales for the rolling 12-month period. We are also in an expansive phase in medical imaging IT, with major investments in delivery capacity in parallel with transitioning our business to service sales instead of product sales.
The Group’s profitability for the nine-month period exceeded our target operating margin, even if variations between individual quarters still are significant. We will have to live with this for a while yet. The important things in the long term are that we continue to have satisfied customers and that we are continuing to grow.
Healthcare and data security are both areas that are expected to grow for a long time to come, and that are relatively unaffected by the economic climate. While our strategic investment in service sales is having a short-term negative impact on our financial outcome and growth, it will be beneficial in the long term. Not least because Sectra’s customers are satisfied and stay with us for a long time. With loyal customers and long-term relationships combined with a strong brand in growing areas, we have every reason to remain optimistic about the future.”
Read the attached interim report for further CEO comments and information.
Presentation of the interim report
Torbjörn Kronander, President and CEO of Sectra AB, and Jessica Holmquist, CFO of Sectra AB, will present the financial report and answer questions. The presentation will be held in English.
Time: March 8, 2024 at 10:00 a.m. CET
Follow live or listen to the recording afterward: https://investor.sectra.com/Q3report2324
This information constitutes information that Sectra AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and/or the Swedish Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out below, at 8:15 a.m. (CET) on March 8, 2024.
CONTACT:
For further information, please contact:
Dr. Torbjörn Kronander, President and CEO, Sectra AB, +46 (0) 705 23 52 27
The following files are available for download:
Sectra’s nine-month report 2023/2024 |
|
https://news.cision.com/sectra/i/sectra-tiger-s-stationary,c3275902 |
Sectra Tiger/S stationary |
https://news.cision.com/sectra/i/torbjorn-kronander–ceo-and-president-sectra-ab,c3275904 |
Torbjörn Kronander, CEO and President Sectra AB |
https://news.cision.com/sectra/i/sectra-s-radiology-solution,c3275903 |
Sectra’s radiology solution |
SOURCE Sectra
HANGZHOU, China, July 12, 2024 /PRNewswire/ -- Nano Labs Ltd (Nasdaq: NA) ("we," the "Company" or…
HOUSTON, July 12, 2024 /PRNewswire/ -- Inhance Technologies welcomes the opportunity to engage with the…
CHICAGO, July 12, 2024 /PRNewswire/ -- The global high-throughput screening market is poised for substantial growth,…
WESTFORD, Mass., July 12, 2024 /PRNewswire/ -- According to SkyQuest, the global 3D Cell Culture…
PUNE, India, July 12, 2024 /PRNewswire/ -- Stellar Market Research, a leading Healthcare business research…
SAN JUAN, Puerto Rico and LAUSANNE, Switzerland, July 12, 2024 /PRNewswire/ -- ImmuneAGE Bio raised…